- 抑制劑
- 化合物庫
- 抗體
- 生物試劑
- 新產(chǎn)品
- 聯(lián)系我們
中文名稱:(-)-表沒食子兒茶素沒食子酸酯
EGCG ((-)-Epigallocatechin Gallate)是從綠茶中分離的一種有效的抗氧化劑Polyphenol flavonoid。抑制telomerase和DNA methyltransferase, 阻滯EGF受體和HER-2受體的激活,抑制脂肪酸合成酶以及谷氨酸脫氫酶的活性。
EGCG ((-)-Epigallocatechin Gallate) Chemical Structure
CAS: 989-51-5
相關(guān)產(chǎn)品 | BIBR 1532 Costunolide RHPS 4 methosulfate Cycloastragenol | 點擊展開 |
---|---|---|
相關(guān)化合物庫 | FDA藥物庫 天然產(chǎn)物庫 凋亡分子化合物庫 DNA損傷/ DNA修復化合物庫 細胞周期化合物庫 | 點擊展開 |
細胞系 | 實驗類型 | 給藥濃度 | 孵育時間 | 活性描述 | 文獻信息 |
---|---|---|---|---|---|
human MDA435/LCC6MDR cells | Function assay | 10 μM | 5 days | Modulation of P-gp (unknown origin) transfected in human MDA435/LCC6MDR cells assessed as reversible of paclitaxel resistance measured as IC50 for paclitaxel at 10 uM after 5 days by CellTiter 96 Aqueous assay, IC50=0.1226 μM | 25985195 |
human Caco-2 cells | Growth inhibition assay | 25 μM | 6 days | Growth inhibition of human Caco-2 cells at 25 uM after 6 days | 18324763 |
mouse 3T3 cells | Function assay | 1-20 μM | 12 h | Antimigratory activity against Swiss albino mouse 3T3 cells assessed as increase of cell numbers at 1 to 20 uM after 12 hrs by by scratch-wound assay | 21080642 |
human Jurkat cells | Function assay | 10-55 μM | 24 h | Inhibition of TNFalpha-induced NF-kappaB activation in human Jurkat cells at 10 to 55 uM after 24 hrs by electrophoretic mobility shift assay | 21080642 |
human Raji cells | Growth inhibition assay | 10 μM | 48 h | Growth inhibition against human Raji cells assessed as cell viability at 10 uM after 48 hrs by trypan blue based microscopic analysis in presence of superoxide dismutase | 21434603 |
human PC3 cells | Proliferation assay | 10-100 μM | 48 h | Antiproliferative activity against human PC3 cells at 10 to 100 uM after 48 hrs by hemocytometric cell counting method | 23867167 |
human A431 cells | Function assay | 100 μM | 12 h | Reduction of clustering of GFP-GPI in lipid rafts of human A431 cells at 100 uM after 12 hrs by confocal microscopic analysis | 24456004 |
human SKBR3 cells | Function assay | 200μM | 30 mins | Downregulation of ErbB2 protein expression in human SKBR3 cells in serum free medium at 200 uM after 30 mins by immunofluorescence staining-based confocal microscopic analysis | 24456004 |
human 293T cells | Function assay | 50 μM | 12 h | Inhibition of DYRK1A in human 293T cells assessed as reduction of GLI1 transcription activity at 50 uM after 12 hrs by dual-luciferase reporter gene assay | 22154664 |
CHO cells | Cytotoxic?assay | 48 h | Cytotoxicity against CHO cells expressing OATP1B3 haplotype 1 after 48 hrs by fluorescence based CellTiter-Glo assay, IC50=3.2 μM | 23327877 | |
MDCK cells | Function assay | 4 days | Antiviral activity against influenza A virus (A/swine/OH/511445/2007(H1N1)) Oh7 infected in MDCK cells assessed as inhibition of viral replication after 4 days by quantitative RT-PCR, ED50=8.3 μM | 22115591 | |
human HL60 cells | Proliferation assay | 3 days | Antiproliferative activity against human HL60 cells after 3 days, IC50=9.4 μM | 18693020 | |
HSC-T6 cells? | Function assay | 48 h | Antifibrotic activity against rat HSC-T6 cells assessed as inhibition of proliferation after 48 hrs by BrdU incorporation assay, IC50=9.9 μM | 21504848 | |
mouse RAW264.7 cells | Function assay | 5 days | Inhibition of RANKL-induced osteoclastogenesis in mouse RAW264.7 cells assessed as decrease in TRAP-positive multi-nucleated cells after 5 days, IC50=29.8 μM | 21456521 | |
human A431 cells | Proliferation assay | 48 h | Antiproliferative activity against human A431 cells overexpressing ErbB in serum-free medium assessed as cell viability after 48 hrs by WST-1 assay, EC50=38 μM | 24456004 | |
human MDA-MB-231 cells | Proliferation assay | 24 h | Antiproliferative activity against human MDA-MB-231 cells after 24 hrs by MTT assay | 22459208 | |
human HepG2 cells | Function assay | 24 h | Inhibition of oleic acid-induced triglyceride over-accumulation in human HepG2 cells incubated for 24 hrs relative to untreated control | 21824690 | |
human HepG2 cells | Function assay | 24 h | Antioxidant activity in human HepG2 cells assessed as reduction of oleic acid-induced ROS generation incubated for 24 hrs by DHCF-DA based fluorimetric assay relative to untreated control | 21824690 | |
human MDA-MB-231 cells | Proliferation assay | 24 h | Antiproliferative activity against human MDA-MB-231 cells after 24 hrs by MTT assay | 22459208 | |
human K562 cells | Function assay | 24 h | Induction of 67 kDa laminin receptor expression in human K562 cells after 24 hrs by flow cytometry analysis | 21434603 | |
human HL60 cells | Function assay | 24 h | Induction of 67 kDa laminin receptor expression in human HL60 cells after 24 hrs by flow cytometry analysis | 21434603 | |
SH-SY5Y cells | Function assay | Neuroprotection against beta-amyloid peptide 1-42-induced toxicity in human SH-SY5Y cells assessed as lactate dehydrogenase release, EC50=0.03987 μM | 19138859 | ||
Sf9 cells | Function assay | Inhibition of His6-tagged human recombinant DNMT1 expressed in insect Sf9 cells assessed as reduction in DNA methyltransferase activity using 5'-biotinylated 45-bp unmethylated or hemimethylated oligonucleotide substrates and [3H]-AdoMet by liquid scintillation counting method, IC50=0.5 μM | 25406944 | ||
human U937 cells | Function assay | Inhibition of telomerase in human U937 cells, IC50=1 μM | 22413845 | ||
human HeLa cells | Function assay | Inhibition of telomerase in human HeLa cells using 5'-AAT CCG TCG AGC AGA GTT-3' as substrate incubated for 15 mins prior to extension reaction followed by compound washout by spin-telomeric repeat amplification protocol, IC50=1.08 μM | 22413845 | ||
mouse 3T3-L1 cells | Function assay | Inhibition of G6PD-mediated NADPH production in mouse 3T3-L1 cells, IC50=25 μM | 18313308 | ||
HSC-T6 cells | Proliferation assay | Antiproliferative activity against rat HSC-T6 cells assessed as reduction in cell viability, IC50=29.8 μM | 25322455 | ||
點擊查看更多細胞系數(shù)據(jù) |
產(chǎn)品描述 | EGCG ((-)-Epigallocatechin Gallate)是從綠茶中分離的一種有效的抗氧化劑Polyphenol flavonoid。抑制telomerase和DNA methyltransferase, 阻滯EGF受體和HER-2受體的激活,抑制脂肪酸合成酶以及谷氨酸脫氫酶的活性。 | |||||
---|---|---|---|---|---|---|
靶點 |
|
體外研究(In Vitro) | ||||
體外研究活性 | (-)-Epigallocatechin gallate在健康細胞中具有強效抗氧化作用,并降低氧化損傷,作為抗血管生成和抗腫瘤劑,也是腫瘤細胞對化療應答的調(diào)節(jié)劑。(-)-Epigallocatechin gallate具有多種抗腫瘤作用,例如抗增殖,抗血管新生,阻斷各種癌細胞轉(zhuǎn)化,細胞周期阻滯和抑制腫瘤轉(zhuǎn)移。(-)-Epigallocatechin gallate通過調(diào)節(jié)多個腫瘤相關(guān)的細胞信號通路(調(diào)節(jié)關(guān)鍵信號蛋白的表達水平,例如核因子-κB, MAPKs和激活蛋白-1,EGFR,IGF,COX-2)影響腫瘤基因的甲基化和配體與膜受體結(jié)合發(fā)揮抗腫瘤效果。[1] (-)-Epigallocatechin gallate具有免疫調(diào)節(jié)作用。多種類型的免疫細胞在先天的和適應性免疫系統(tǒng)中都會不同程度受到(-)-Epigallocatechin gallate的影響。在這些作用中,對T細胞的顯著作用被反復證明,包括T細胞激活,增殖,分化和細胞因子產(chǎn)生?;诨加凶陨砻庖呒膊〉膭游锬P偷难芯繄蟮辣砻鳎G茶/EGCG處理會使動物的病情好轉(zhuǎn)。[2] (-)-Epigallocatechin gallate具有抗感染活性。(-)-Epigallocatechin gallate的以不同激活模式產(chǎn)生的抗病毒活性在很多種屬的病毒中被證實,例如逆轉(zhuǎn)錄病毒,正粘病毒科和黃病毒科,還包括重要的人類病原細菌,如人類免疫缺陷病原體,甲型流感病毒和丙型肝炎病毒。[3] |
|||
---|---|---|---|---|
實驗圖片 | 檢測方法 | 檢測指標 | 實驗圖片 | PMID |
Western blot | β-catenin / p-AKT / Cyclin D1 p-MAPK / MAPK Notch1 / Notch2 | 28693189 | ||
Growth inhibiton assay | Cell proliferation Cell viability | 23525843 |
NCT Number | Recruitment | Conditions | Sponsor/Collaborators | Start Date | Phases |
---|---|---|---|---|---|
NCT05758571 | Recruiting | Interstitial Pneumonia|Neoplasms Malignant |
Shandong Cancer Hospital and Institute |
January 5 2023 | Phase 1|Phase 2 |
分子量 | 458.37 | 分子式 | C22H18O11 |
CAS號 | 989-51-5 | SDF | Download EGCG ((-)-Epigallocatechin Gallate) SDF |
儲存條件(自收到貨起) | |||
體外溶解度 |
DMSO : 92 mg/mL ( (200.71 mM) ;DMSO吸濕會降低化合物溶解度,請使用新開封DMSO) Ethanol : 92 mg/mL (200.71 mM) Water : 20 mg/mL (43.63 mM) |
摩爾濃度計算器 |
體內(nèi)溶解度 現(xiàn)配現(xiàn)用,請按從左到右的順序依次添加,澄清后再加入下一溶劑 |
動物體內(nèi)配方計算器 |
動物體內(nèi)配方計算器(澄清溶液)
第一步:請輸入基本實驗信息(考慮到實驗過程中的損耗,建議多配一只動物的藥量)
第二步:請輸入動物體內(nèi)配方組成(配方適用于不溶于水的藥物;不同批次藥物配方比例不同,請聯(lián)系Selleck為您提供正確的澄清溶液配方)
計算結(jié)果:
工作液濃度: mg/ml;
DMSO母液配制方法: mg 藥物溶于μL DMSO溶液(母液濃度mg/mL,注:如該濃度超過該批次藥物DMSO溶解度,請先聯(lián)系Selleck);
體內(nèi)配方配制方法:取μL DMSO母液,加入μL PEG300,混勻澄清后加入μL Tween 80,混勻澄清后加入μL ddH2O,混勻澄清。
體內(nèi)配方配制方法:取μL DMSO母液,加入μL Corn oil,混勻澄清。
注意:1. 首先保證母液是澄清的;
2.一定要按照順序依次將溶劑加入,進行下一步操作之前必須保證上一步操作得到的是澄清的溶液,可采用渦旋、超聲或水浴加熱等物理方法助溶。
在訂購、運輸、儲存和使用我們的產(chǎn)品的任何階段,您遇到的任何問題,均可以通過撥打我們的熱線電話400-668-6834,或者技術(shù)支持郵箱tech@selleck.cn,直接聯(lián)系到我們。我們會在24小時內(nèi)盡快聯(lián)系您。
如果有其他問題,請給我們留言。
* 必填項